Feed aggregator

Climate-change adaptation: Designer reefs

news@nature - 6 min 6 sec ago

Biologists are directing the evolution of corals to prepare them to fight climate change.

Nature 508 444 doi: 10.1038/508444a

The soft power of sailfish bills

news@nature - 6 min 6 sec ago

High-speed video reveals unusually powerful motion, but specialized weapon can also gently nudge prey.

Nature News doi: 10.1038/nature.2014.15086

FDA discourages use of morcellators in removal of uterine fibroids

news@nature - 6 min 6 sec ago

Tissue-shredding tool used in minimally invasive surgery risks spreading undetected cancer.

Nature News doi: 10.1038/nature.2014.15085

Tamiflu report comes under fire

news@nature - 6 min 6 sec ago

Conclusions on stockpiling of antiviral drugs challenged.

Nature 508 439 doi: 10.1038/508439a

Chile quake defies expectations

news@nature - 6 min 6 sec ago

Smaller-than-expected tremor has scientists scrambling to redefine rules for areas of extreme seismic stress.

Nature 508 440 doi: 10.1038/508440a

RNA interference rebooted

news@nature - 6 min 6 sec ago

Gene-silencing technique yields promising treatments for liver-linked disorders.

Nature 508 443 doi: 10.1038/508443a

Animals with human rights make researchers run scared

news@nature - 6 min 6 sec ago

Legally, dogs and cats are moving closer to personhood. A new book says this poses problems for biomedical researchers and veterinarians.

Nature News doi: 10.1038/nature.2014.15095

MRSA spreads in households

news@nature - 6 min 6 sec ago

Drug-resistant bacteria have found refuge in residences in New York outbreak.

Nature News doi: 10.1038/nature.2014.15080

Mechanism behind mega-heatwaves pinpointed

news@nature - 6 min 6 sec ago

Two recent record hot spells traced to feedback loop between dry soils and trapped air.

Nature News doi: 10.1038/nature.2014.15078

How to make graphene in a kitchen blender

news@nature - 6 min 6 sec ago

Nature News Blog doi:

NSF pulls support for quake observatory

news@nature - 6 min 6 sec ago

Troubled project sought to observe tremors from deep within the San Andreas fault.

Nature News doi: 10.1038/nature.2014.15076

X-ray method could improve nuclear screening

news@nature - 6 min 6 sec ago

Rapid imaging technique adapted from medical applications shows promise in detection of nuclear materials.

Nature News doi: 10.1038/nature.2014.15071

Moon dust probe crashes

news@nature - 6 min 6 sec ago

Nature News Blog doi:

Bouncing neutrons probe dark energy on a table-top

news@nature - 6 min 6 sec ago

An experiment measuring gravity's effects at the quantum scale finds no deviations from Newton's laws.

Nature News doi: 10.1038/nature.2014.15062

How to build a Neanderthal

news@nature - 6 min 6 sec ago

Epigenetic maps help to explain how archaic humans differed from modern ones despite having very similar DNA sequences.

Nature News doi: 10.1038/nature.2014.15063

Female insect uses spiky penis to take charge

news@nature - Tue, 04/22/2014 - 8:21pm

Brazilian cave creatures's marathon sex sessions extract nourishment along with sperm from reluctant male.

Nature News doi: 10.1038/nature.2014.15064

FDA Panel Snubs Morphine-Oxycodone Combo

Headlines from MedPage Today® - Tue, 04/22/2014 - 5:42pm
(MedPage Today) -- An FDA advisory committee has voted unanimously against approval of an oral combination of morphine and oxycodone (Moxduo) for acute pain.

Stroke Rounds: AVM Outcomes Better With Conservative Tx (CME/CE)

Headlines from MedPage Today® - Tue, 04/22/2014 - 5:33pm
(MedPage Today) -- Patients with unruptured arteriovenous malformations (AVMs) in the brain appeared to fare better over the long term by following a conservative strategy and avoiding interventions, a nonrandomized, observational study suggested.

Benzos Equal for Kids With Status Epilepticus (CME/CE)

Headlines from MedPage Today® - Tue, 04/22/2014 - 5:30pm
(MedPage Today) -- Diazepam proved equal to lorazepam for effectiveness and safety in treating children with status epilepticus, surprising the randomized trial's investigators and others in the field.

Pradaxa, Xarelto, Eliquis: NOACs' Reversal a Key?

Headlines from MedPage Today® - Tue, 04/22/2014 - 4:46pm
(MedPage Today) -- The new oral anticoagulants, or NOACs -- dabigatran (Pradaxa), rivaroxaban (Xarelto), and Eliquis (apixaban) -- are touted for their safety, efficacy, and ease of use, but they have one drawback in common: There is no antidote.
Syndicate content